Risks

Guest Episode

Cardiovascular disease, the number one killer: development, biomarkers, apoB, cholesterol, brain health, and more

Ep. #334 with Tom Dayspring, M.D.
Longevity

AMA

Special AMA: Peter on exercise, important labs, building good habits, promising longevity research, and more

Ep. #329
Nutrition

AMA

Preventing cognitive decline, nutrition myths, lowering blood glucose, apoB, and blood pressure, and more

Ep. #306 (AMA #60)
Medications & supplements

AMA

Metabolic health & pharmacologic interventions: SGLT-2 inhibitors, metformin, GLP-1 agonists, and the impact of statins

Ep. #279 (AMA #53)
Longevity

Podcast Episode

Special episode: Peter answers questions on longevity, supplements, protein, fasting, apoB, statins, and more

Ep. #276
Risks

Premium Article

Statins: effectiveness, safety, and common myths on their role in ASCVD prevention

Risks

Free Article

A case study on the importance of taking charge of one’s own health

Risks

Guest Episode

The confusion around HDL and its link to cardiovascular disease

Ep. #240 with Dan Rader, M.D.
Risks

AMA

Understanding apoB, LDL-C, Lp(a), and insulin as risk factors for cardiovascular disease

Ep. #238 (AMA #43)
Longevity

AMA

Medicine 3.0, developments in the field of aging, healthy habits in times of stress, and more

Ep. #231 (AMA #41)
Risks

Guest Episode

Cardiovascular disease in women: prevention, risk factors, lipids, and more

Ep. #230 with Erin Michos, M.D.
Risks

Podcast Episode

Understanding cardiovascular disease risk, cholesterol, and apoB

Ep. #229
Risks

Heart Disease: Labs & Diagnostic Tests

Risks

Free Article

First Case of Human PCSK9 Gene-Editing

Risks

Free Article

For triglycerides, “normal” may not be “optimal”

Risks

Intro to lipids & lipoproteins: why there is no ‘bad’ or ‘good’ cholesterol

Risks

AMA

What Causes Heart Disease?

Ep. #203 (AMA #34)
Risks

Guest Episode

When CAC Tests Are Useful and When They Are Not

with Allan Sniderman, M.D.
Risks

Why early prevention of atherosclerosis is critical

with Allan Sniderman, M.D.
Risks

Guest Episode

Preventing Atherosclerosis: 2 Fatal Flaws with the "10 Year Risk" Approach

with Allan Sniderman, M.D.
Risks

How early and aggressive lowering of apoB could change the course of ASCVD

Cholesterol

Free Article

Why a recent study hasn’t shaken my faith in statins

Risks

Guest Episode

Cardiovascular disease and why we should change the way we assess risk

Ep. #185 with Allan Sniderman, M.D.
Risks

Free Article

Early risk assessment markers to delay cardiovascular disease